CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 22 enrolled
Drug / intervention
Azelaic acid 15% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02147691
NCT02147691Phase 4Completed
CompareCT.gov

Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

Derm Research, PLLC·interventional·Posted May 28, 2014·Updated Sep 30, 2015

In Brief

A Phase 4 clinical trial evaluating Azelaic acid 15% and Brimonidine 0.33% for Acne Rosacea. Completed, enrolled 22 participants across 1 site.

Detailed Summary

The pilot study will investigate whether combination treatment of Finacea 15% Gel and Brimonidine 0.33% Gel could be more effective than Brimonidine 0.33% Gel monotherapy in treating both the papules/pustules and erythema associated with rosacea.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Rosacea
CountriesUnited States
CollaboratorsBayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 28, 2014
Enrollment StartMay 1, 2014
Primary CompletionJan 1, 2015
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12.1 years ago

Interventions

Azelaic acid 15%drug

Applied to the face each AM and PM

Brimonidine 0.33%drug

Applied to the face each AM 30 minutes after the application of Azelaic acid 15%